Mammalian target of rapamycin (mTOR; FRAP; RAFT1); transforming growth factor-β1 (TGFB1; TGFβ1) BriefCommunication Pages: 1084 - 1084
Ataxia telangiectasia mutated (ATM); poly(ADP-ribose) polymerase (PARP) BriefCommunication Pages: 1089 - 1089
AT rich interactive domain 1A (ARID1A); protein phosphatase 2, regulatory subunit A α (PPP2R1A) BriefCommunication Pages: 1090 - 1090
Angiotensin II type 1 receptor (AGTR1); transforming growth factor-β (TGFB; TGFβ) BriefCommunication Pages: 1092 - 1092
Staphylocoagulase precursor (coa); von Willebrand factor binding protein (vWbp) BriefCommunication Pages: 1095 - 1095
v-abl Abelson murine leukemia viral oncogene homolog 1 (ABL1; c-Abl); parkin (PARK2) BriefCommunication Pages: 1103 - 1103
Culture of human pluripotent stem (hPS) cells in non-muscle myosin II (MYH10; NMHCII)-depleted conditions to improve viability and increase available cells for clinical applications BriefCommunication Pages: 1104 - 1104
In vitro human cell-based model of the human blood brain barrier (BBB) BriefCommunication Pages: 1106 - 1106
Malarial vaccine based on an adenoviral vector containing a B cell epitope BriefCommunication Pages: 1107 - 1107
Radiolabeled, non-natural amino acid PET imaging of brain tumors BriefCommunication Pages: 1108 - 1108